Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Traumatic Brain Injury Study Highlights: Key Updates from the 2020 Brain Trauma Foundation Guidelines (Rapp et al., 2025)
TRAUMATIC BRAIN INJURY STUDY HIGHLIGHTS – Updated Review of the Management of and Guidelines for Traumatic Brain Injury by Rapp, A., et al.
Navigating Cognitive Challenges After Traumatic Brain Injury: Practical Insights from Dr. Mea Sung
Dealing with Traumatic Brain Injury (TBI) can feel overwhelming, but recovery is possible.
Meet Moleac at the 19th World Congress of Neurosurgery (WFNS) in Dubai (Booth 26)
Moleac will be attending the 19ᵗʰ World Congress of Neurosurgery (WFNS) in Dubai from December 1–5, 2025.
Xin Yan Lim Speaks at Bpifrance Singapore Seminar on the Future of Health
Highlights from the Neurological Disorders Scientific Summit in Rome (20–23 November 2025)
We are pleased to share highlights from the Neurological Disorders Scientific Summit held in Rome, Italy, from 20 to 23 November 2025.
Alzheimer’s Disease Pathophysiology and NeuroAiD’s Multimodal Mechanism of Action
Alzheimer’s Disease is a complex neurodegenerative disorder affecting millions worldwide.
Understanding Post-Stroke Spasticity: Causes, Symptoms & Management (Dr. Mea Sung Interview)
What causes spasticity after a stroke, and how can it be managed?
Kuala Lumpur Dinner Symposium — Expanding Approaches in Alzheimer’s Disease Management
ASOC 2025 Nairobi — Strengthening Collaboration to Transform Stroke Care Across Africa
Moleac was proud to participate in the 5th African Stroke Organization Conference (ASOC 2025) held in Nairobi, Kenya, from 3–5 November.
Moleac at WFNS 2025 in Dubai (December 1–5, 2025)
We are thrilled to announce our participation at the 19ᵗʰ World Congress of Neurosurgery (WFNS), in Dubai from December 1–5, 2025.
